Splanchnic and renal vasoconstrictor and metabolic responses to neuropeptide Y in resting and exercising man
- 1 June 1992
- journal article
- Published by Wiley in Acta Physiologica Scandinavica
- Vol. 145 (2) , 139-149
- https://doi.org/10.1111/j.1748-1716.1992.tb09349.x
Abstract
The local clearance of neuropeptide Y (NPY) and whether NPY influences splanchnic and renal metabolism in man have not been investigated previously. The influence of NPY on splanchnic and renal blood flows at physiologically elevated levels has also not been investigated. The effects of a 40-min constant NPY infusion (3 pmol kg-1 min-1) at rest and during 130 min of exercise (50% of Vo2max) were studied in six healthy subjects and compared with resting and exercising subjects receiving no NPY. Blood samples were drawn from arterial, hepatic and renal vein catheters for the determination of blood flows (indicators: cardiogreen and paraaminohippuric acid [PAH]), NPY, catecholamines, glucose, lactate and glycerol. NPY infusion was accompanied by: (1) significant fractional extraction of NPY-like immunoreactivity (NPY-Li) by splanchnic tissues at rest (58±5%) and during exercise (53±6%), while no arterial–venous differences could be detected across the kidney; (2) a reduction in splanchnic and renal blood flows of up to 18 and 13% respectively (P < 0.01–0.001) at rest without any additional changes during exercise; and (3) metabolic changes as reflected in: (a) a more marked fall in arterial glucose during exercise compared to the reference group (P < 0.05); (b) a 35% lower splanchnic glucose release (P < 0.01) during exercise due to diminished glycogenolysis (P < 0.01); and (c) a lower arterial lactate level (18%P < 0.05) together with unchanged splanchnic lactate uptake during exercise, suggesting reduced lactate production by extrahepatic tissues. The disappearance of plasma NPY-Li after the infusions was biphasic with two similar half-lives at rest (4 and 39 min) and during exercise (3 and 43 min).Keywords
This publication has 28 references indexed in Scilit:
- Release of neuropeptide Y upon haemorrhagic hypovolaemia in relation to vasoconstrictor effects in the pigActa Physiologica Scandinavica, 1987
- Neuropeptide Y: Intrapancreatic neuronal localization and effects on insulin secretion in the mouseCell and tissue research, 1987
- Neuropeptide Y and Calcitonin Gene-Related Peptide: Effects on Glucagon and Insulin Secretion in the MouseEndocrine Research, 1987
- Vasoconstrictor effects in vivo and plasma disappearance rate of neuropeptide Y in manLife Sciences, 1986
- Plasma neuropeptide Y‐like immunoreactivity and catecholamines during various degrees of sympathetic activation in manClinical Physiology and Functional Imaging, 1986
- Frequency- and reserpine-dependent chemical coding of sympathetic transmission: Differential release of noradrenaline and neuropeptide Y from pig spleenNeuroscience Letters, 1986
- Co-release of neuropeptide Y and catecholamines during physical exercise in manBiochemical and Biophysical Research Communications, 1985
- Neuropeptide Y is a potent inhibitor of cyclic AMP accumulation in feline cerebral blood vesselsActa Physiologica Scandinavica, 1985
- Radioimmunoassay for neuropeptide Y (NPY): chromatographic characterization of immunoreactivity in plasma and tissue extractsScandinavian Journal of Clinical and Laboratory Investigation, 1985
- Indocyanine Green Clearance and Estimated Hepatic Blood Flow during Mild to Maximal Exercise in Upright Man *Journal of Clinical Investigation, 1964